Latest news


P4A attends the Festival of Genomics in Boston

Partners4Access will attend the Festival of Genomics in Boston on October 3rd, 2017. Sophie Schmitz, Managing Partner at P4A will be there meeting representatives of the research and patient community as well as the pharmaceutical industry. The Festival celebrates the achievements made within genomics and human health. The 1200 attendees aim to “shape ideas, challenge […]

Read More


P4A participated at the Vecht voor Kinderen Rally

At the weekend (17/06), Sophie participated in the Dutch Vecht voor Kinderen Rally (fight for children rally), supporting a number of children charities including a children’s hospice, child cancer organisation that provides children with wigs and various development programmes in Africa. Those sponsoring and charity activities have a long tradition  at Partners4Access, in particular supporting […]

Read More


Sophie Schmitz attended world orphan drug congress

Many rare disease patients lay their hope in gene-therapy development. However, recent experience with Glybera (uniQure) has shown difficulties faced in the launch and access. During the World Orphan Drug Congress in Washington this month, Partners4Access had the opportunity to get latest insights from a German sickness fund that reimbursed Glybera and the CEO of […]

Read More


Partners4Access is pleased to announce the addition of Rosa Pandolfo to the London office

Continued focus is ‘Orphan Drug Solutions’ a partnership approach to ensuring a successful global launch. Partners4Access, the global access experts for orphan drugs, is pleased to announce that Rosa Pandolfo joined the company’s London Office as Senior Consultant. This addition helps further secure P4A’s position as the go-to partner for orphan drug manufacturers. Schmitz, Managing […]

Read More

Partners4Access collaborates with Cambridge University

          Partners4Access, the global access experts for orphan drugs, has entered into a collaboration with Cambridge University to support their Graduate Professional Practice Programme.  Partners4Access will support a student from the Masters in Bioscience Enterprise program develop their dissertation, providing a platform to engage in a corporate-level environment.  Sophie Schmitz, Managing Partner at Partners4Access said, […]

Read More


Partners4Access participates in the “Shut up legs charity ride” 2017

Following the Partners4Access tradition to support rare disease charity runs and charity events, Julie Brennan from Verto Health, our UK Partner for local access implementation activities, will cycle for the Epilepsy Society. The event “Shut up legs charity ride” supported by Jens Voigt former professional road bicycle racer takes place for the 5th time. All […]

Read More


Partners4Access runs for International Rare Diseases Day

Sophie Schmitz, Managing Director of Partners4Access participated in an international run to raise money and awareness on International Rare Diseases Day (28th February 2017). The run was in support of Sanofi Genzyme’s campaign. Sophie completed a 12km run this morning along a route that followed the scenic environs of the river Rhine.  Sophie’s achievement will […]

Read More


Hot topics in pharma and orphan drugs

I attended this year’s pharma pricing and market access conference in London with attendees across the pharmaceutical industry, payer and HTA bodies and patient representatives. While following the talks, panel discussions and roundtable debates, a few overarching key topics crystallised: –          Germany – AMNOG changes AMNOG, the German pharmaceutical law is regularly adapted to changes […]

Read More


Patners4Access sponsor this year’s Hilversum Rotary Santa Run

Partners4Access sponsors this year’s Hilversum Rotary Club Santa Run taking place on 17 December. Sophie Schmitz, the Managing Director, participates to raise awareness for kidney diseases. The run supports 2 key charities: the Dutch Kidney Foundation and Toy Donations for Underprivileged Children. The Dutch Kidney Foundation helps patients with kidney diseases and their relatives in […]

Read More


Partners4Access represented at World Orphan Drug Congress

 The World Orphan Drug Congress in Brussels in November was the another conference Partners4Access attended. This year’s agenda focused on the challenges orphan drug manufacturers are facing in the regulatory and HTA environment. Topics as “value for money of orphan medicines” is a challenge our clients are facing every day. High profile health economists discussed […]

Read More